Patent Law Weblog
recent posts
- Bayer Files Suit Against Trio of COVID-19 Vaccine Makers
- Allen v. Cooper (4th Cir. 2026)
- To Require an Inventor ID, or Not to Require an Inventor ID – That Is the Question
- Federal Circuit Refuses to Switch District Court’s Finding for Nintendo
- Supreme Court to Resolve Dispute Over Marketing of “Skinny Labeled” Generics
about
Month: January 2014
-
Strafford will be offering a webinar/teleconference entitled "Patent Inventorship: Best Practices for Determination and Correction — Drawing the Line Between Inventor and Contributor, Leveraging Lessons From Year One of the AIA" on February 27, 2014 from 1:00 to 2:30 pm (EST). Jill K. MacAlpine, Ph.D., of Finnegan Henderson Farabow Garrett & Dunner and Lauren L.…
-
By Kevin E. Noonan & Donald Zuhn — On Tuesday, we presented a live webinar on the "Top Patent Law Stories of 2013." The webinar covered ten of the fourteen stories that made it onto Patent Docs seventh annual list of top biotech/pharma patent stories. Posts on our top fourteen stories can be found here…
-
By Andrew Williams — Earlier today, in Medtronic, Inc. v. Mirowski Family Ventures, LLC, the Supreme Court held that "when a licensee seeks a declaratory judgment against a patentee to establish that there is no infringement, the burden of proving infringement remains with the patentee." Justice Breyer wrote the opinion for a unanimous Court, reversing…
-
By Donald Zuhn — Last month, the Federal Circuit dismissed an appeal by Institut Pasteur of a determination by the Board of Patent Appeals and Interferences affirming the rejection of claim 14 of U.S. Patent No. 7,309,605 in an inter partes reexamination requested by Precision BioSciences. The Federal Circuit also reversed the Board's affirmance of…
-
By Josh Bosman — Last week, the U.S. Patent and Trademark Office issued U.S. Patent No. 8,628,920, which is entitled "Method for early diagnosis of liver cancer and prediction of metastasis." The '920 patent, which is assigned to National Tsing Hua University in Taiwan, contains claims to a method of determining the risk of liver…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Biosuccess Biotech Co. Ltd. v. Rich Pharmaceuticals Inc. et al.2:14-cv-00310; filed January 14, 2014 in the Central District of California • Plaintiff: Biosuccess Biotech Co. Ltd.• Defendants: Rich Pharmaceuticals Inc.; Imagic LLC; Richard L…
-
January 21, 2014 – "Top Patent Law Stories of 2013" (McDonnell Boehnen Hulbert & Berghoff LLP) – 10:00 am to 11:15 am (CT) January 22, 2014 – European biotech patent law update (D Young & Co) – 4:00 am, 7:00 am, and 12:00 pm (EST) January 22-23, 2014 – Patent Reform*** (American Conference Institute) –…
-
American Conference Institute (ACI) will be holding the next session of its FDA Boot Camp conference on March 12-13, 2014 in New York, NY. ACI faculty will help attendees: • Master the basics of the application and approval processes for drugs, biologics, and devices;• Comprehend the structure of the FDA and the roles of the…
-
American Conference Institute (ACI) will be holding its 4th Advanced Summit on Medical Device Patents on March 24-26, 2014 in Chicago, IL. The conference will allow attendees to: • Utilize the new AIA inter partes review and post-grant review procedures to your advantage in the crowded and litigious medical device patent field;• Prepare for increased…
-
Strafford will be offering a webinar/teleconference entitled "Proactive Patent Procurement and Prosecution Strategies: Minimizing the Threat of Post-Grant Challenges — Insulating Your Patent Portfolio From New Threats" on February 13, 2014 from 1:00 to 2:30 pm (EST). Christopher A. Bullard of Oblon Spivak McClelland Maier & Neustadt and Scott A. McKeown of Oblon Spivak McClelland…
Patent Docs 